News

Winners of the 2024 Pharmapack Europe Awards are Announced

January 25, 2024

The 2024 Pharmapack Europe Award winners include companies involved in ground-breaking innovations in novel drug delivery solutions, reusable connected devices, and recyclable packaging.

Takeda’s Subcutaneous Immunoglobulin Receives FDA Approval for Maintenance Therapy of Rare Neuromuscular Disorder

January 24, 2024

Takeda has received FDA approval for HYQVIA, a subcutaneous immunoglobulin for the maintenance treatment of chronic inflammatory demyelinating polyneuropathy.

KBI Biopharma and Argonaut Manufacturing Services Team Up on Drug Substance and Drug Product Manufacturing Solutions

January 24, 2024

Under a new alliance, KBI Biopharma and Argonaut Manufacturing Services will combine their strengths to offer end-to-end biopharma development and CGMP manufacturing solutions.

Abzena Launches New Cell Line Development Platforms

January 22, 2024

Abzena has launched its AbZelect platforms, designed for improving cell line development.

EMA Looks Back at Medicines Approved in 2023

January 19, 2024

The agency recommended 77 drugs for marketing authorization in 2023, including 39 new APIs.

Novartis Acquires Calypso Biotech for up to $425 Million

January 18, 2024

The acquisition will give Novartis full rights to CALY-002, Calypso’s lead product candidate.

CDER Approved 55 Novel Drugs in 2023

January 18, 2024

FDA’s Center for Drug Evaluation and Research released its report on new drugs approved in 2023.

Charles River Launches Off-the-Shelf Rep/Cap Plasmids for AAV Vector Manufacturing

January 17, 2024

Charles River’s off-the-shelf rep/cap plasmids are intended to simplify gene therapy supply chains.

Bora Pharmaceuticals Fuels Global Expansion with Acquisition in US

January 17, 2024

The acquisition marks a pivotal expansion for the company into the US market.

EMA Starts Safety Review of CAR T-Cell Medicines

January 17, 2024

The agency is reviewing data on secondary malignancies related to T-cells for approved CAR T-cell medicines.